AHCPR mammography guidelines
This article was originally published in The Gray Sheet
Executive SummaryWill be used by FDA in its development of standards to implement the Mammography Quality Screening Act of 1992, according to agency staffers. The Agency for Health Care Policy and Research-funded panel developing the clinical practice guidelines recently held a public hearing in Bethesda, Maryland to gain input on the document. The guidance, entitled "Quality Determinants for Mammography," is expected to be finalized late this year.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.